Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies — 42%
vitamin K1 is lowered
100%
—
cholangiocarcinoma —
29%
beriberi
73%
—
jaundice —
20%
benign tumors of the small intestine
54%
—
sclerosing cholangitis —
19%
small bowel cancer
51%
—
cholangitis —
19%
adenocarcinoma of the colon
49%
—
radiation therapy —
18%
hemorrhagic disease of newborns
48%
—
oncology in the anamnesis —
18%
rash burning
47%
—
radiation damage —
17%
volume of gallbladder is lowered
47%
—
mechanical jaundice —
17%
chronic enterocolitis
47%
—
k94 diagnosis of gastrointestinal diseases —
16%
biliary cirrhosis of the liver
46%
—
metastases —
16%
monthly prolonged
46%
—
cancer in the anamnesis —
16%
small intestine resection
46%
—
primary sclerosing cholangitis —
15%
chronic enteritis
44%
—
bone cancer —
15%
flies in front of the eyes
44%
—
vascular tumor —
15%
spot pain
44%
—
breast cancer —
14%
enterocolitis
41%
—
pancreatectomy —
14%
nosebleed
40%
—
increased —
14%
bleeding
40%
—
history of surgery —
14%
lowered
55%
13%
cholestasis —
14%
vitamin c reduced
39%
—
breast tumor —
13%
dysbacteriosis
39%
—
solid tumors —
13%
petechiae
39%
—
allergy to medications —
13%
scurvy
39%
—
osteosarcoma —
13%
external bleeding
39%
—
chronic cholangitis —
13%
hepatosis fatty
39%
—
breast sarcoma —
12%
gallbladder stones
38%
—
angioplasty —
12%
dark eyes
38%
—
pain in the gallbladder —
12%
hepatosis
38%
—
volume of gallbladder is increased —
12%
liver atrophy
38%
—
helminths —
12%
enteritis
38%
—
hyperthermia —
12%
childhood diseases
37%
—
history of laparoscopic surgery —
12%
intestinal resection
37%
—
history of pancreatic surgery —
12%
burning of the skin
37%
—
malignant hyperthermia —
12%
red dots
37%
—
intolerance to drugs —
12%
pancreatopathy
37%
—
cholecystectomy —
12%
duodenitis
37%
—
testicular pain —
12%
mucous hyperemia
36%
—
bone metastases —
11%
consequences of suppression
36%
—
drug allergy —
11%
the consequences of taking antibiotic therapy
36%
—
rapid weight loss —
11%
bruise
36%
—
loss body weight —
11%
small-point rash
36%
—
increased sensitivity —
11%
hemorrhages on the skin
35%
—
scrotum pain —
11%
cirrhosis of the liver
34%
—
prolonged jaundice —
11%
the skin is dark
34%
—
yellow sclera —
11%
malabsorption
33%
—
fighting —
11%
red rash
33%
—
dropsy testicles —
11%
enteropathy
33%
—
thin skin —
10%
hematoma
33%
—
high temperature —
10%
gallbladder cancer
53%
19%
change in appetite —
10%
burns
32%
—
chronic colitis —
10%
liver resection
44%
11%
feeling of heat —
10%
hepatitis
31%
—
allergy —
10%
rupture duodenal dysfunction
31%
—
history of liver surgery —
9%
intestinal insufficiency syndrome
31%
—
painful swelling —
9%
subacute condition
29%
—
wounds heal poorly —
9%
tumors of the large intestine
40%
10%
weight change —
9%
tumors of the small intestine
48%
21%
strong character —
9%
pancreatic cancer
42%
15%
a history of endoscopic surgery —
9%
scratch
33%
8%
fluid in the abdominal cavity —
9%
impaired function of the small intestine
33%
9%
increased ESR —
9%
bowel cancer
36%
13%
patient's condition —
9%
dysfunction of the gallbladder
35%
13%
skin cancer —
9%
colitis
35%
13%
intestinal mucosa —
8%
soreness of the skin
29%
7%
peptic ulcer —
8%
inflammatory bowel diseases
31%
11%
helps others —
8%
there are no complaints
27%
7%
muscle pain —
8%
skin problems
26%
9%
aching —
8%
gastrointestinal problems
27%
10%
abdominal pain —
8%
liver cancer
38%
22%
cysts —
8%
diseases of the gastrointestinal tract
27%
12%
periods of exacerbation —
8%
intestinal tumor
34%
19%
high fever —
8%
inflammation
25%
11%
no appetite —
8%
liver problems
29%
15%
needs attention —
8%
hypertrophy biliary tract
33%
19%
itchy skin —
8%
benign neoplasms
31%
18%
lymphosarcoma —
8%
cancer
28%
16%
enlarged liver —
8%
oncology
25%
15%
pain when touched —
8%
suspicion —
8%
general weakness —
8%
wound —
7%
blood diseases —
7%
impaired arterial function —
7%
nausea —
7%
necrosis —
7%
exhaustion —
7%
acute condition —
7%
vomiting —
7%
consequences of taking medications —
6%
clonorchiasis —
6%